PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Download All
Learn about PARP inhibitor–based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides, podcasts and a ClinicalThought.
Charles J. Ryan, MD

CME Expert-Authored, Interactive Online Activity

Review expert insights on PARP inhibitor combination approaches including combinations with AR-directed therapy and immune checkpoint inhibitors.

Charles J. Ryan, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 12, 2021 Expired: April 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue